BioTissue Stock

biotissue.comHealthcare / BioTech & PharmaFounded: 2006

TissueTech manufactures ocular, surgical, wound care, and soft tissue products that are marketed under these subsidiaries.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for BioTissue, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access BioTissue’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like BioTissue.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

BioTissue stock FAQs

plusminus

Can you buy BioTissue stock?

As BioTissue is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like BioTissue, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy BioTissue stock?

To invest in a private company like BioTissue through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell BioTissue stock?

Yes, you may be able to sell your BioTissue stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell BioTissue stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your BioTissue stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is BioTissue a public company?

No, BioTissue is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is BioTissue’s stock price?

BioTissue is a privately held company and therefore does not have a public stock price. However, you may access BioTissue’s private market stock price with Forge Data.
plusminus

What is BioTissue’s stock ticker symbol?

BioTissue does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Aspect Biosystems and Novo Nordisk are collaborating on a $2.6 billion project to develop therapeutics for type 1 diabetes and obesity. The companies aim to create 3D, biologically functional tissues containing insulin-producing cells that can be implanted without the need for immunosuppressive drugs. The partnership will fund up to four products for the treatment of diabetes and/or obesity, with Aspect eligible to receive up to $650 million per project based on future milestones, plus royalties on product sales.
Newcastle-based 3D Bio-Tissues (3DBT) has produced the world's first 100% cultivated pork steak, which replicates the flavour and texture of traditional pork. The meat was made using 3DBT's patented, serum-free and animal-free cell booster, City-mixTM. 3DBT, owned by BSF Enterprise plc, plans to produce a full-scale fillet of cultivated pork and work with manufacturers and supermarkets to distribute the product.
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.